SCHEMBL712162

SCHEMBL712162

O=C1c2ccccc2C(=O)c2c1ccc1[nH]cnc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
POLB P06746 3/20 0.45
RXFP1 Q9HBX9 1/20 0.45
DPP4 P27487 1/20 0.44
MAPT P10636 8/20 0.42
MAPK1 P28482 7/20 0.42
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MAOA P21397 3/20 0.42
CYP3A4 P08684 2/20 0.42
MCL1 Q07820 2/20 0.42
ALOX12 P18054 2/20 0.42
RECQL P46063 2/20 0.42
MAOB P27338 1/20 0.42
KDM4E B2RXH2 1/20 0.42
BCL2 P10415 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10939607 0.78 MAOA (0.42) ALDH1A1POLBMAPTMAPK1MEN1
SCHEMBL8121267 0.75 DPP4 (0.42) ALDH1A1POLBDPP4MAPTMEN1
SCHEMBL17576233 0.73 ALDH1A1 (0.42) ALDH1A1POLBMAPTMAPK1MEN1
SCHEMBL3860252 0.72 DPP4 (0.62) ALDH1A1POLBDPP4MAPTMEN1
SCHEMBL2396625 0.72 ALDH1A1 (0.44) ALDH1A1POLBMAPTMAPK1MEN1
Anthraquinone SCHEMBL28686015 0.72 IDO1 (0.55) ALDH1A1POLBRXFP1MAPTMAPK1
SCHEMBL13735962 0.71 MEN1 (0.47) ALDH1A1POLBRXFP1MAPTMAPK1
SCHEMBL16134542 0.71 TERT (0.44) ALDH1A1POLBMAPTMAPK1MEN1
SCHEMBL17702673 0.71 ALDH1A1 (0.45) ALDH1A1POLBMAPTMAPK1MEN1
SCHEMBL16134473 0.68 L3MBTL1 (0.49) ALDH1A1POLBMAPTMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124637-B2 Anthra [1, 2-d]imidazole-6,11-dione derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2012-02-28 US disclosed
US-8124637-B2 Anthra [1, 2-d]imidazole-6,11-dione derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2012-02-28 US disclosed
US-8067454-B2 Thio-substituted Anthra [1, 2-d] imidazole- 6, 11-dione derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-11-29 US disclosed
US-8067454-B2 Thio-substituted Anthra [1, 2-d] imidazole- 6, 11-dione derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-11-29 US disclosed
US-20110207719-A1 Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed
US-20110207719-A1 Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed
US-20110207727-A1 Thio-subsituted Anthra [1, 2-d] imidazole- 6, 11-dione Dervatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed
US-20110207727-A1 Thio-subsituted Anthra [1, 2-d] imidazole- 6, 11-dione Dervatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed
US-4963451-A USED IN ELECTROPHOTOGRAPHY, SOLAR BATTERY AND SENSORS SHARP KABUSHIKI KAISHA (JP) 1990-10-16 US disclosed
US-4908457-A 1,2,4,5-benzoylenebis(anthraquinone[1,2-d]imidazole) compounds SHARP KABUSHIKI KAISHA (JP) 1990-03-13 US disclosed
EP-0320200-A1 1,2,4,5-Benzoylenebis(anthraquinone [1,2-d] imidazole) compounds and photosensitive members containing them SHARP KABUSHIKI KAISHA (JP) 1989-06-14 EP disclosed
EP-0008063-B1 AZOMETHINE DERIVATIVES OF ANTHRAQUINONES, METHODS FOR THEIR PREPARATION, THEIR USE IN THE PIGMENTATION OF ORGANIC MACROMOLECULAR COMPOUNDS AND THE MATERIALS THUS OBTAINED BAYER AG (DE) 1982-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207727-A1 Thio-subsituted Anthra [1, 2-d] imidazole- 6, 11-dione Dervatives, Preparation Method and application thereof TERT, ACIN1, TERF2 ALDH1A1 204/4885POLB 834/4885RXFP1 4664/4885
US-20110207719-A1 Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof TERT, ACIN1, AK2 ALDH1A1 267/4885POLB 1154/4885RXFP1 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.